X4 PHARMACEUTICALS INC
COM · CUSIP 98420X103
2
institutional holders
-91 vs Q1 2025
653.3k
shares reported held*
$1.2mreported value*
0 new
0 added
2 reduced
90 sold out
net sold ≈ $185.6m (-97.7m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.90.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 60 |
| Q4 2022 | 54 |
| Q1 2023 | 61 |
| Q2 2023 | 97 |
| Q3 2023 | 92 |
| Q4 2023 | 94 |
| Q1 2024 | 99 |
| Q2 2024 | 101 |
| Q3 2024 | 99 |
| Q4 2024 | 91 |
| Q1 2025 | 93 |
| Q2 2025 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2023 | 38 | 42 |
| Q4 2023 | 44 | 35 |
| Q1 2024 | 38 | 37 |
| Q2 2024 | 53 | 36 |
| Q3 2024 | 44 | 31 |
| Q4 2024 | 35 | 42 |
| Q1 2025 | 41 | 34 |
| Q2 2025 | 0 | 92 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2024 | $278.8k | $106.1k | 0.38 |
| Q4 2024 | $549.7k | $134.4k | 0.24 |
| Q1 2025 | $202.1k | $30.9k | 0.15 |
| Q2 2025 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| Bain Capital Life Sciences Investors, LLC | Sold out | -16.9m |
| NEA Management Company, LLC | Reduced | -14.5m |
| BlackRock, Inc. | Sold out | -11.4m |
| VANGUARD GROUP INC | Sold out | -8.1m |
| ACORN CAPITAL ADVISORS, LLC | Reduced | -7.2m |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | Sold out | -7.0m |
| ORBIMED ADVISORS LLC | Sold out | -6.8m |
| UBS Group AG | Sold out | -5.0m |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -3.6m |
| STATE STREET CORP | Sold out | -3.1m |
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| NEA Management Company, LLC 0.07% of their portfolio | 499.6k $949.2k | Reduced -14.5m |
| ACORN CAPITAL ADVISORS, LLC 0.19% of their portfolio | 153.7k $292.1k | Reduced -7.2m |